Evaluating the Economic Impact of Member Attitudes on Managed Care Disease Management Programs

摘要

Estimates of the cost/benefit of a disease management program is explicit (or implicit) in almost all cases reported in this or similar publications. But do these analyses take all the economic factors into consideration when dealing with the reality of managed care health plans? One major factor that is almost never considered is the ability of most plan members to disenroll from a plan that has a policy toward disease management that they deem adverse to their health and welfare. The study by CareData Reports on women's reactions to the availability of new Pap Test technology is one example of how significant the economic impact of this stakeholder group could be.